Key Takeaways
- Insulet Corporation is showcasing its vision for liveable technology at CES 2026 through an immersive booth experience and expert panel session
- The company’s Omnipod 5 automated insulin delivery system embodies liveable technology by helping people manage their diabetes through trustworthy automation
- Insulet will host a panel discussion on "The Rise of Liveable Tech: Calm, Intelligent, and Human-First" to explore new possibilities for the future of connected health
- The company’s booth will offer a hands-on journey into how automation and human-first design can make life with diabetes simpler and more empowering
Introduction to Insulet Corporation
Insulet Corporation, a global leader in tubeless insulin pump technology, has announced its debut at the Consumer Electronics Show (CES) 2026. The company will showcase its vision for liveable technology through an immersive booth experience, expert panel session, and media demonstrations. Liveable technology reflects Insulet’s philosophy for the future of connected health, which emphasizes effortless, intelligent systems that support daily life. As digital health accelerates, people increasingly want technology that lightens the mental load and surfaces insights only when they matter.
Showcasing Liveable Technology at CES 2026
At CES, Insulet will demonstrate a bold vision for liveable technology—intuitive and adaptive solutions that fit naturally into life. The company will offer an immersive experience demonstrating how Omnipod makes connected health simple and empowering. Insulet’s Chief Growth Officer, Manoj Raghunandanan, stated that "CES is where the future of technology takes shape, and Insulet is proud to help bring the voice of those living with diabetes into that future." He emphasized that the company’s goal is to ease the burden of managing diabetes by creating technology that fits naturally into life.
The Omnipod 5 Automated Insulin Delivery System
For people with type 1 or insulin-intensive type 2 diabetes, keeping blood glucose levels in a safe range is time-consuming and mentally exhausting. Insulet will highlight how Omnipod 5, the tubeless automated insulin delivery system, embodies liveable technology by helping people manage their diabetes through trustworthy automation that works seamlessly in the background. The system delivers personalized, automated insulin delivery without tubing, fingersticks, or multiple daily injections, exemplifying Insulet’s commitment to calm, human-centered innovation at the intersection of consumer experience, advanced technology, and healthcare.
Insulet’s Presence at CES 2026
Key elements of Insulet’s CES 2026 presence include a featured panel discussion on "The Rise of Liveable Tech: Calm, Intelligent, and Human-First," which will explore new possibilities for the future of connected health. The panel will bring together innovators, clinicians, and real-world voices to discuss how connected health is evolving toward insight-driven, emotionally supportive systems that reduce cognitive burden for people with chronic conditions. Additionally, the Insulet booth will offer a hands-on journey into how automation and human-first design can make life with diabetes simpler and more empowering.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller.
Conclusion
In conclusion, Insulet Corporation is making a significant impact at CES 2026 by showcasing its vision for liveable technology and its commitment to simplifying life for people with diabetes. The company’s Omnipod 5 automated insulin delivery system is a prime example of liveable technology, helping people manage their diabetes through trustworthy automation. As the company continues to innovate and push the boundaries of connected health, it is likely to make a lasting impact on the lives of people with diabetes and other chronic conditions.
